ATAP is pleased to report that a Virginia bill aimed at regulating PBMs (HB 1177), championed by Delegate Todd Pillion (R, 4th), has passed both the House and the Senate and is now headed to Governor Ralph Northam’s desk. Should the Governor sign HB 1177 into law, Virginia will become the first state to enact PBM legislation during the 2018 session.
Read MoreATAP is pleased to report that a Florida bill aimed at regulating PBMs (HB 351) has cleared another important hurdle: the Health and Human Services Committee yesterday voted unanimously in favor of passing the bill out of committee. ATAP sent a letter to Committee Members earlier this week expressing our support for HB 351 and urging them to support this legislation and vote in favor of the bill.
Read MoreThe Alliance for Transparent & Affordable Prescriptions (ATAP) applauds the White House for recognizing the increasingly harmful role of pharmacy benefit managers (PBMs) in the prescription drug market in a report released Friday outlining policy options to reduce drug prices and encourage medical innovation.
Read MoreOn February 7, ATAP sent a letter to New Hampshire legislators expressing its support for HB 1529, which seeks to increase transparency for pharmacy benefit managers (PBMs) by requiring them to annually disclose the amount of rebates and discounts received from drug manufacturers. The bill is currently being considered by the House Commerce and Consumer Affairs Committee, following a public hearing on its provisions.
Read MoreThe Alliance for Transparent & Affordable Prescriptions (ATAP), a coalition of provider and patient groups concerned about the practices of pharmacy benefit managers (PBMs), started off the new year by adding three new members to its coalition: Kentuckiana Rheumatology Alliance (KRA), Ohio Association of Rheumatology (OAR), and International Foundation for Autoimmune & Autoinflammatory Arthritis (IFAA).
Read MoreThe Alliance for Transparent & Affordable Prescriptions (ATAP) is encouraged by President Trump’s statement during the State of the Union address last night that reducing prescription drug prices is one of his “greatest priorities.”
Read MoreATAP joined the Ohio Pharmacists Association (OPA) and over twenty additional organizations in applauding new legislation introduced by Representative Scott Lipps (R-Franklin) and Representative Thomas West (D-Canton) that aims to end a secretive practice that is causing patients to pay more than they should at the pharmacy counter.
Read MoreATAP urges CMS to adopt a policy requiring sponsors to include all price concessions at the point of sale for Medicare beneficiaries.
Read MoreBy Dr. Robert Levin, President of the Florida Society of Rheumatology
Mary is a 45-year-old patient in my practice with severe rheumatoid arthritis. She was incapacitated. Her illness prevented her from working, and also made it difficult to dress, cook, do housework and other everyday tasks that most of us take for granted.